Role of Multidrug Resistance Proteins 2 and/or 4, and DMPS and DMSA in the Renal
Role of Multidrug Resistance Proteins 2 and/or 4, and DMPS and DMSA in the Renal
批准号:
7409598
负责人:
CHRISTY C BRIDGES
金额:
$7.16万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-04-20 至 2011-03-31
关键词:
AcidsAffectAftercareAnimal ModelAnimalsAnionsApicalBloodBody BurdenCanis familiarisCarrier ProteinsCell membraneCellsCharacteristicsChelating AgentsComplexControl AnimalCountryDMSADataDevelopmentDiamondDistalEpithelial CellsExcisionExposure toFutureGlutathioneHealthHepatobiliaryHumanIndividualIntoxicationIonsKidneyLocalizedMDCK cellMediatingMercuryMercury PoisoningMetalcaptaseMetalsModelingMulti-Drug ResistanceNa(+)-K(+)-Exchanging ATPaseObject AttachmentOrganOrganic Anion TransportersOxidoreductaseP-GlycoproteinsParticipantPathway interactionsPharmaceutical PreparationsPlayProteinsPurposeRattusRoleS cerevisiae MRP2 proteinSiteSodiumStructureSubstrate SpecificitySuccimerSulfhydryl CompoundsTestingTherapeuticToxic Environmental SubstancesToxic effectTubular formationUnithiolUrineWaterXenobioticsapical membranebasebasolateral membranebody systemdicarboxylate-binding proteinin vitro Modelinhibitor/antagonistinnovationinsightnovel therapeuticsprotein transportresearch study
中文摘要
描述(申请人提供):人类继续接触有机(CH3Hg2+)和无机(Hg2+)形式的汞。这些环境毒物影响许多器官系统,但它们积累和毒性的主要目标是肾脏,特别是近端小管。大量研究表明,金属螯合剂2,3-二硫代-1-丙磺酸(DMPS)和Meso-2,3-二硫代琥珀酸(DMSA)可以从近端肾小管上清除CH3Hg+和Hg2+。这种去除似乎涉及细胞内汞离子与这些螯合剂之一形成强键的连接步骤,以及随后的输出步骤,其中这些汞-螯合物被分泌到管腔中。然而,这种分泌的实际机制仍然不清楚。然而,根据多药耐药蛋白(MRP)的特性,很可能有一个或多个这些蛋白参与了DMPS和DMSA介导的汞离子的输出。因此,本研究的目的是验证MRP2和/或MPR4在DMPS和DMSA介导的CH3Hg+和Hg2+从肾脏中的清除中起作用的假设。为了验证这一假设,我们将使用不表达mrp2蛋白的tr大鼠,以及稳定转基因OAT1和MRP2或MRP4的Madin-Darby犬肾(MDCK)细胞。我们将首先研究DMPS和DMSA对对照组和TR型大鼠对CH3Hg2+和Hg2+的处理和处置的影响。作为替代模型,转基因的MDCK细胞将被用来研究MRP2和MRP4在各种汞的输出中的作用。使用这些细胞可以分离MRP2和MRP4的活性,并能够更准确地描述每种蛋白质在汞物种运输中的作用。总之,这些研究将确定MRP2和/或MRP4(S)是否在DMPS和DMSA介导的近端肾小管细胞CH3Hg+和Hg2+分泌中发挥作用(S)。从这些实验中获得的数据将作为更广泛的一系列研究的基础。目前和未来的研究将对人类健康具有重要意义,因为它们将成为开发汞中毒其他治疗方案的基础。汞是一种普遍存在的环境毒物,人类经常接触到。从拟议的研究中获得的数据将提供与体内汞清除方式有关的重要信息。这些数据将作为开发汞中毒其他治疗方法的基础。
英文摘要
DESCRIPTION (provided by applicant): Humans continue to be exposed to organic (CH3Hg+) and inorganic (Hg2+) forms of mercury. These environmental toxicants affect numerous organ systems, but a major target for their accumulation and toxicity is the kidney, specifically the proximal tubule. Numerous studies have shown that CH3Hg+ and Hg2+ can be removed from proximal tubules by treatment with the metal chelators, 2,3-dimercapto-1-propanesulfonic acid (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA). This removal appears to involve a conjugation step wherein intracellular mercuric ions form strong bonds with one of these chelators, and a subsequent export step where these mercury-chelator complexes are secreted into the tubular lumen. The actual mechanisms involved in this secretion, however, remain undefined. Yet based on the characteristics of the multidrug resistance proteins (MRP), it is likely that one or more of these proteins are involved in the DMPS- and DMSA- mediated export of mercuric ions. Therefore, the purpose of the current proposal is to test the hypothesis that MRP2, and/or MPR4, play a role in the DMPS- and DMSA-mediated elimination of CH3Hg+ and Hg2+ from the kidney. To test this hypothesis, we will use TR- rats, which do not express the Mrp2 protein, and Madin-Darby canine kidney (MDCK) cells stably transfected with OAT1 and MRP2 or MRP4. We will first examine the effect of DMPS and DMSA on the handling and disposition of CH3Hg+ and Hg2+ in control and TR- rats. As an alternative model, the transfected MDCK cells will be used to study the roles of MRP2 and MRP4 in the export of various species of mercury. The use of these cells allows for the separation of MRP2 and MRP4 activities and enables a more accurate characterization of the role of each protein in the transport of mercuric species. Collectively, these studies will determine whether MRP2 and/or MRP4 play(s) a role in the DMPS- and DMSA- mediated secretion of CH3Hg+ and Hg2+ from proximal tubular cells. The data obtained from these experiments will serve as the basis for a more expanded set of studies. The current and future studies will be important to human health in that they will serve as the basis for the development of additional therapeutic regimes for mercury poisoning. Mercury is a prevalent environmental toxicant to which humans are exposed frequently. The data obtained from the proposed studies will provide important information related to the way in which mercury is eliminated from the body. These data will serve as the basis for the development of additional treatments for mercury poisoning.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.placenta.2009.06.005
发表时间:
2009-09
期刊:
PLACENTA
影响因子:
3.8
作者:
[Bridges, C. C., Joshee, L., Zalups, R. K.]
通讯作者:
Zalups, R. K.
DOI:
10.1371/journal.pone.0073559
发表时间:
2013
期刊:
PloS one
影响因子:
3.7
作者:
[Bridges CC, Joshee L, van den Heuvel JJ, Russel FG, Zalups RK]
通讯作者:
Zalups RK
Proximal Tubular Transport of Mercury and Effects of Reduced Renal Mass
-
批准号:8099325
-
项目类别:
-
资助金额:$47.1万
-
财政年份:2011
-
负责人:CHRISTY C BRIDGES
-
依托单位:
Role of Multidrug Resistance Proteins 2 and/or 4, and DMPS and DMSA in the Renal
-
批准号:7240203
-
项目类别:
-
资助金额:$7.31万
-
财政年份:2007
-
负责人:CHRISTY C BRIDGES
-
依托单位:
MECHANISMS FOR RENAL UPTAKE OF MERCURY
-
批准号:6906404
-
项目类别:
-
资助金额:$5.15万
-
财政年份:2003
-
负责人:CHRISTY C BRIDGES
-
依托单位:
MECHANISMS FOR RENAL UPTAKE OF MERCURY
-
批准号:6694550
-
项目类别:
-
资助金额:$4.64万
-
财政年份:2003
-
负责人:CHRISTY C BRIDGES
-
依托单位:
MECHANISMS FOR RENAL UPTAKE OF MERCURY
-
批准号:6789311
-
项目类别:
-
资助金额:$4.89万
-
财政年份:2003
-
负责人:CHRISTY C BRIDGES
-
依托单位:
海外基金